Walgreens Boots Alliance (NASDAQ:WBA) Issues Quarterly Earnings Results

Walgreens Boots Alliance (NASDAQ:WBA) announced its quarterly earnings results on Friday. The pharmacy operator reported $0.51 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.38 by $0.13, RTT News reports. The business had revenue of $39.50 billion for the quarter, compared to analyst estimates of $37.40 billion. Walgreens Boots Alliance had a positive return on equity of 14.23% and a negative net margin of 5.85%. The company’s quarterly revenue was up 7.6% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.66 earnings per share. Walgreens Boots Alliance updated its FY 2025 guidance to 1.400-1.800 EPS and its FY25 guidance to $1.40-$1.80 EPS.

Walgreens Boots Alliance Stock Performance

NASDAQ:WBA opened at $11.76 on Friday. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.68 and a quick ratio of 0.37. The business has a fifty day simple moving average of $9.26 and a two-hundred day simple moving average of $9.89. Walgreens Boots Alliance has a 1 year low of $8.08 and a 1 year high of $24.93. The company has a market capitalization of $10.15 billion, a P/E ratio of -1.17, a P/E/G ratio of 1.36 and a beta of 0.64.

Walgreens Boots Alliance Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Thursday, December 12th. Shareholders of record on Monday, November 18th were given a $0.25 dividend. This represents a $1.00 dividend on an annualized basis and a yield of 8.50%. The ex-dividend date was Monday, November 18th. Walgreens Boots Alliance’s dividend payout ratio is currently -9.99%.

Wall Street Analyst Weigh In

Several brokerages have issued reports on WBA. Truist Financial cut their price target on Walgreens Boots Alliance from $13.00 to $10.00 and set a “hold” rating on the stock in a report on Monday, October 7th. Morgan Stanley dropped their target price on Walgreens Boots Alliance from $9.00 to $7.00 and set an “underweight” rating on the stock in a report on Friday, October 11th. TD Cowen dropped their target price on Walgreens Boots Alliance from $16.00 to $14.00 and set a “buy” rating on the stock in a report on Tuesday, October 22nd. Evercore ISI raised their target price on Walgreens Boots Alliance from $7.50 to $10.00 and gave the company an “in-line” rating in a report on Wednesday, October 16th. Finally, Royal Bank of Canada dropped their target price on Walgreens Boots Alliance from $13.00 to $9.00 and set a “sector perform” rating on the stock in a report on Wednesday, December 4th. Four investment analysts have rated the stock with a sell rating, nine have issued a hold rating and two have issued a buy rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Hold” and a consensus target price of $12.58.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.